trending Market Intelligence /marketintelligence/en/news-insights/trending/MK-_2wRfx3G_WCKw4VoSSA2 content esgSubNav
In This List

Kura Oncology prices $50.1M common stock offering

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Kura Oncology prices $50.1M common stock offering

Kura Oncology Inc. priced an underwritten public offering of 7,700,000 common shares at $6.50 apiece, for expected gross proceeds of about $50.1 million.

The company also granted underwriters a 30-day option to buy up to an additional 1,155,000 common shares.

The offering is expected to close on or around Aug. 16, subject to customary closing conditions.

Leerink Partners and Cowen are acting as joint book-running managers for the offering, with JMP Securities and Oppenheimer & Co. as co-lead managers.